Follicular lymphoma grade II, intrathoracic lymph nodes
ICD-10 C82.12 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, intrathoracic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade II indicates an intermediate level of aggressiveness, with a higher proliferation rate than grade I but lower than grade III. When this lymphoma affects the intrathoracic lymph nodes, it typically presents with symptoms such as lymphadenopathy, which may be accompanied by B-symptoms like fever, night sweats, and weight loss. Diagnosis is often confirmed through biopsy and histological examination, which reveals the characteristic follicular architecture. Staging is crucial for treatment planning and involves imaging studies such as CT scans or PET scans to assess the extent of disease spread. Treatment options may include watchful waiting for asymptomatic patients, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. The prognosis varies based on the stage at diagnosis and the patient's overall health.
Detailed clinical notes on symptoms, staging, and treatment plans.
Diagnosis and management of newly diagnosed follicular lymphoma, treatment response evaluations.
Ensure accurate grading and staging documentation to support treatment decisions.
Imaging reports detailing lymph node involvement and any changes over time.
CT or PET scans for staging and monitoring treatment response.
Clear documentation of imaging findings related to lymphoma staging is essential.
Used to evaluate overall health and detect blood disorders in patients with lymphoma.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure CBC results are correlated with clinical findings.
Common symptoms include painless swelling of lymph nodes, fatigue, fever, night sweats, and unexplained weight loss, known as B-symptoms.
